% alzhub.org library filter
% Source: https://alzhub.org/research?author=%C3%96hrfelt+A
% 9 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{olsson2016-27068280,
  author  = {Olsson, B. and Lautner, R. and Andreasson, U. and Öhrfelt, A. and Portelius, E. and Bjerke, M. and Hölttä, M. and Rosén, C. and others},
  title   = {{CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis}},
  journal = {The Lancet. Neurology},
  year    = {2016},
  doi     = {10.1016/s1474-4422(16)00070-3},
  pmid    = {27068280},
  url     = {https://doi.org/10.1016/s1474-4422(16)00070-3}
}

@article{backstrom2015-26258692,
  author  = {Bäckström, D. C. and Eriksson Domellöf, M. and Linder, J. and Olsson, B. and Öhrfelt, A. and Trupp, M. and Zetterberg, H. and Blennow, K. and others},
  title   = {{Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2015.1449},
  pmid    = {26258692},
  url     = {https://doi.org/10.1001/jamaneurol.2015.1449}
}

@article{heslegrave2016-26754172,
  author  = {Heslegrave, A. and Heywood, W. and Paterson, R. and Magdalinou, N. and Svensson, J. and Johansson, P. and Öhrfelt, A. and Blennow, K. and others},
  title   = {{Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease}},
  journal = {Molecular neurodegeneration},
  year    = {2016},
  doi     = {10.1186/s13024-016-0071-x},
  pmid    = {26754172},
  url     = {https://doi.org/10.1186/s13024-016-0071-x}
}

@article{hall2012-22925882,
  author  = {Hall, S. and Öhrfelt, A. and Constantinescu, R. and Andreasson, U. and Surova, Y. and Bostrom, F. and Nilsson, C. and Håkan, W. and others},
  title   = {{Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders}},
  journal = {Archives of neurology},
  year    = {2012},
  doi     = {10.1001/archneurol.2012.1654},
  pmid    = {22925882},
  url     = {https://doi.org/10.1001/archneurol.2012.1654}
}

@article{ohrfelt2023-36192174,
  author  = {Öhrfelt, A. and Benedet, A. L. and Ashton, N. J. and Kvartsberg, H. and Vandijck, M. and Weiner, M. W. and Trojanowski, J. Q. and Shaw, L. M. and others},
  title   = {{Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000201417},
  pmid    = {36192174},
  url     = {https://doi.org/10.1212/wnl.0000000000201417}
}

@article{kvartsberg2015-25533203,
  author  = {Kvartsberg, H. and Duits, F. H. and Ingelsson, M. and Andreasen, N. and Öhrfelt, A. and Andersson, K. and Brinkmalm, G. and Lannfelt, L. and others},
  title   = {{Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2015},
  doi     = {10.1016/j.jalz.2014.10.009},
  pmid    = {25533203},
  url     = {https://doi.org/10.1016/j.jalz.2014.10.009}
}

@article{ohrfelt2016-26754805,
  author  = {Öhrfelt, A. and Axelsson, M. and Malmeström, C. and Novakova, L. and Heslegrave, A. and Blennow, K. and Lycke, J. and Zetterberg, H.},
  title   = {{Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone}},
  journal = {Multiple sclerosis (Houndmills, Basingstoke, England)},
  year    = {2016},
  doi     = {10.1177/1352458515624558},
  pmid    = {26754805},
  url     = {https://doi.org/10.1177/1352458515624558}
}

@article{ohrfelt2016-27716408,
  author  = {Öhrfelt, A. and Brinkmalm, A. and Dumurgier, J. and Brinkmalm, G. and Hansson, O. and Zetterberg, H. and Bouaziz-Amar, E. and Hugon, J. and others},
  title   = {{The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2016},
  doi     = {10.1186/s13195-016-0208-8},
  pmid    = {27716408},
  url     = {https://doi.org/10.1186/s13195-016-0208-8}
}

@article{ohrfelt2016-27504117,
  author  = {Öhrfelt, A. and Johansson, P. and Wallin, A. and Andreasson, U. and Zetterberg, H. and Blennow, K. and Svensson, J.},
  title   = {{Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease}},
  journal = {Dementia and geriatric cognitive disorders extra},
  year    = {2016},
  doi     = {10.1159/000447239},
  pmid    = {27504117},
  url     = {https://doi.org/10.1159/000447239}
}